The proposed financing consists of a loan to Procaps S.A. ("Procaps" or "the Company") in an aggregate amount of up to US$20 million for a term of up to three years. The project aims to support the expansion plan of Procaps, a company dedicated to the development, production and marketing of pharmaceutical drugs and advanced drug delivery system. The loan will properly finance the Company's long cash cycles, reducing short-term pressure, and provide additional resources for continued Research and Development investment and capital expenditures, both regulatory and growth-related.
|Private Actor 1||Private Actor 1 Role||Private Actor 1 Sector||Relation||Private Actor 2||Private Actor 2 Role||Private Actor 2 Sector|
|-||-||-||-||Procaps S.A.||Contractor||Industry and Trade|
For inquiries about the Project please contact:
Name: Sergio A. Mantilla Gómez
Phone number: (575) 371 92 80
Email: email@example.com or firstname.lastname@example.org
ACCESS TO INFORMATION
You can submit a request for information disclosure at:
ACCOUNTABILITY MECHANISM OF IDB / IDB INVEST
The Independent Consultation and Investigation Mechanism (MICI) is the independent complaint mechanism and fact-finding body for people who have been or are likely to be adversely affected by an Inter-American Development Bank (IDB) or Inter-American Investment Corporation (IDB Invest)-funded project. If you submit a complaint to MICI, they may assist you in addressing the problems you raised through a dispute-resolution process with those implementing the project and/or through an investigation to assess whether the IDB or IDB Invest is following its own policies for preventing or mitigating harm to people or the environment. You can submit a complaint by sending an email to MICI@iadb.org. You can learn more about the MICI and how to file a complaint at http://www.iadb.org/en/mici/mici,1752.html (in English) or http://www.iadb.org/es/mici/mici,1752.html (Spanish).